SS

Sukhvinder Singh Kandiala

Active Director Additional Director DIN 08978640
DIN 08978640 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2020
Shareholding value •••• Premium profile

About Sukhvinder Singh Kandiala

Data last updated:

Sukhvinder Singh Kandiala is an Additional Director at Dapcure Pharmaceutical Private Limited (since 2022) and Director at Mapsn Drug Private Limited (since 2020). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Dapcure Pharmaceutical Private Limited at ₹2.1 Lakh (FY 2022).

DIN 08978640
Primary Designation Additional Director
Industry Pharma
First Appointment 01 Dec 2020
Oldest Company Age 6 yrs
Largest company Dapcure Pharmaceutical Private Limited · ₹2.1 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director17 Aug 20222020₹2.1 Lakh (FY 2022)Active
Mapsn Drug Private Limited U85110CT2020PTC010995
Director01 Dec 20202020Active

Board colleagues of Sukhvinder Singh Kandiala

Directorship timeline

Open interactive timeline →
Dapcure Pharmaceutical Private Limited
Mapsn Drug Private Limited
Premium access

Shareholding and investment profile for Sukhvinder Singh Kandiala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sukhvinder Singh Kandiala

Sukhvinder Singh Kandiala currently holds 2 directorships: Dapcure Pharmaceutical Private Limited (Additional Director, since 17 Aug 2022, revenue ₹2.1 Lakh (FY 2022)); Mapsn Drug Private Limited (Director, since 01 Dec 2020).

Sukhvinder Singh Kandiala was first appointed on 01 Dec 2020 as Director at Mapsn Drug Private Limited. The most recent appointment on record is 17 Aug 2022 at Dapcure Pharmaceutical Private Limited.

The current boards of Sukhvinder Singh Kandiala's companies include Daphne Kaur Kandiala (Dapcure Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available